Zhejiang,China

info@bio-mapper.com

Cyfra 21-1

Go Back
Disease Type: Application Platform: , , , , ,

The Cyfra 21-1 antigen can be measured in concentration through a blood test, which is used to diagnose and monitor the progression of certain cancers. However, it is important to note that Cyfra 21-1 is not a highly specific marker and may be influenced by other factors to produce false-positive or false-negative results. Therefore, when diagnosing with Cyfra 21-1, a patient’s clinical symptoms, imaging studies, and other laboratory findings need to be considered.

Cyfra 21-1

 

Cyfra 21-1 antigen lies in its high sensitivity and specificity in the diagnosis and monitoring of certain malignant tumors.

You may also like

Why Choose Bio-Mapper

Provide customized services, and can customize products according to the special needs of customers

We bring you outstanding value with quality, innovation and price.

1

Different project, different platform

Rapid Diagnosis Platform/Allergen Testing Series/Conventional ELISA / CMIA Platform/Animal Testing Series

2

All developed by ourselves

Recombinant Antigen Mono/polyclonal Antibody Conjugated Antigen/Antibody

3

Mature And Perfect Expression System

Prokaryotic Expression System/Eukaryotic Expression System/Mouse Monoclonal Antibody System/Goat/rabbit Polyclonal Antibody System/Natural Protein Extraction and Purification System

4

kinds of machines for producing

Modern precision instruments/AKTA Protein Purifier/High performance liquid chromatography/Gas Chromatograph...

5

Mature SOP for every product

We treat friends with sincerity and maintain our relationship with reliable product.

Let's communicate.

Scroll to Top